FDA Approves Rezafungin Injection for the Treatment of Candidemia, Invasive CandidiasisMarch 27th 2023
Rezafungin (Rezzayo; Cidara Therapeutics Inc, Melinta Therapeutics LLC) is the first new treatment option approved for individuals with candidemia and invasive candidiasis in more than a decade.
Research Finds Impact of Chronic Pain on Daily Life is Biggest Threat to Mental HealthMarch 13th 2023
Persistently pursuing valued goals and adjusting those goals in response to setbacks or obstacles may help explain how some individuals with chronic pain maintain their mental wellbeing.
Experts Debate Approaches to Oral Anticoagulation After AblationMarch 6th 2023
Findings from the AFFIRM trial found increased risks after stopping oral anticoagulant therapy after rhythm control, and the same is true for stopping treatment with oral anticoagulants after successful ablation.
States With Legal Medical, Recreational Cannabis Policies Do Not Have Significantly Higher Rate of Psychosis-Related OutcomesFebruary 2nd 2023
This is the largest known study to consider medical and recreational cannabis policies with US psychosis-related health care claims.
FDA Approves Tocilizumab as First Monoclonal Antibody Treatment of COVID-19January 3rd 2023
Intravenous tocilizumab (Actemra; Genentech) has been approved for the treatment of COVID-19 in individuals who are hospitalized and receiving systemic corticosteroids and supplemental oxygen.
Study Finds SARS-CoV-2 Booster Vaccination Lowers Infections, Hospitalizations, and Deaths in Nursing HomesDecember 16th 2022
There are limited data on the efficacy of boosters for preventing infection and death in nursing home residents, but the findings suggest that boosters may have significantly reduced COVID-19–associated morbidity and mortality in this population.
Data Analysis Shows Significant New Onset Morbidity Post-COVID-19 in Children, Adolescents, AdultsNovember 21st 2022
Although long-term health issues from COVID-19 are a major public health concern, evidence on post-COVID-19 symptoms are still limited, specifically among children and adolescents.
De-Stigmatization of Sexual Assault May Contribute to Related Increase in Emergency Department VisitsOctober 25th 2022
Data show that an increase in sexual assault-related emergency department visits in 2019 may be due to social de-stigmatization of sexual assault during the #metoo movement of that year.
Study: Early Fluoride Exposure Not Found to Have Impact on Childhood DevelopmentOctober 19th 2022
The measures of children’s emotional and behavioral development were assessed by the Strength and Difficulties Questionnaire (SDQ), and executive functioning was measured by the Behavior Inventory of Executive Functioning (BRIEF).
Guselkumab, Golimumab Combination Therapy Achieves Clinical Remission Rate of 47.9% in Patients with Ulcerative ColitisOctober 14th 2022
The rate of clinical remission for adults with moderately to severely active ulcerative colitis was higher than induction and maintenance treatment with either guselkumab alone at 31% or golimumab alone at 20.8%.
More Than 90% of Deaf Community Struggled After Initiation of Mask Mandate During COVID-19 PandemicOctober 5th 2022
These effects were particularly pronounced among those who sign or who are profoundly deaf, whose feelings of disconnect from society had a significantly detrimental impact on their wellbeing.